These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 32094925)

  • 1. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR.
    Cehajic-Kapetanovic J; Xue K; Martinez-Fernandez de la Camara C; Nanda A; Davies A; Wood LJ; Salvetti AP; Fischer MD; Aylward JW; Barnard AR; Jolly JK; Luo E; Lujan BJ; Ong T; Girach A; Black GCM; Gregori NZ; Davis JL; Rosa PR; Lotery AJ; Lam BL; Stanga PE; MacLaren RE
    Nat Med; 2020 Mar; 26(3):354-359. PubMed ID: 32094925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose Range Finding Studies with Two
    Song C; Dufour VL; Cideciyan AV; Ye GJ; Swider M; Newmark JA; Timmers AM; Robinson PM; Knop DR; Chulay JD; Jacobson SG; Aguirre GD; Beltran WA; Shearman MS
    Hum Gene Ther; 2020 Jul; 31(13-14):743-755. PubMed ID: 32414297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations.
    von Krusenstiern L; Liu J; Liao E; Gow JA; Chen G; Ong T; Lotery AJ; Jalil A; Lam BL; MacLaren RE;
    JAMA Ophthalmol; 2023 Mar; 141(3):275-283. PubMed ID: 36757689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa.
    Beltran WA; Cideciyan AV; Lewin AS; Iwabe S; Khanna H; Sumaroka A; Chiodo VA; Fajardo DS; Román AJ; Deng WT; Swider M; Alemán TS; Boye SL; Genini S; Swaroop A; Hauswirth WW; Jacobson SG; Aguirre GD
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2132-7. PubMed ID: 22308428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codon-Optimized RPGR Improves Stability and Efficacy of AAV8 Gene Therapy in Two Mouse Models of X-Linked Retinitis Pigmentosa.
    Fischer MD; McClements ME; Martinez-Fernandez de la Camara C; Bellingrath JS; Dauletbekov D; Ramsden SC; Hickey DG; Barnard AR; MacLaren RE
    Mol Ther; 2017 Aug; 25(8):1854-1865. PubMed ID: 28549772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
    Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
    Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RPGR-associated retinal degeneration in human X-linked RP and a murine model.
    Huang WC; Wright AF; Roman AJ; Cideciyan AV; Manson FD; Gewaily DY; Schwartz SB; Sadigh S; Limberis MP; Bell P; Wilson JM; Swaroop A; Jacobson SG
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5594-608. PubMed ID: 22807293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa.
    Martinez-Fernandez de la Camara C; Cehajic-Kapetanovic J; MacLaren RE
    Expert Opin Emerg Drugs; 2022 Dec; 27(4):431-443. PubMed ID: 36562395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first reported case of a deletion of the entire RPGR gene in a family with X-linked retinitis pigmentosa.
    Mihailovic N; Schimpf-Linzenbold S; Sattler I; Eter N; Heiduschka P
    Ophthalmic Genet; 2022 Oct; 43(5):679-684. PubMed ID: 35652150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene augmentation for X-linked retinitis pigmentosa caused by mutations in RPGR.
    Beltran WA; Cideciyan AV; Lewin AS; Hauswirth WW; Jacobson SG; Aguirre GD
    Cold Spring Harb Perspect Med; 2014 Oct; 5(2):a017392. PubMed ID: 25301933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a Novel Intronic Variant in RPGR With Hypomorphic Phenotype of X-Linked Retinitis Pigmentosa.
    Cehajic-Kapetanovic J; McClements ME; Whitfield J; Shanks M; Clouston P; MacLaren RE
    JAMA Ophthalmol; 2020 Nov; 138(11):1151-1158. PubMed ID: 32970112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice.
    Song C; Conlon TJ; Deng WT; Coleman KE; Zhu P; Plummer C; Mandapati S; Van Hoosear M; Green KB; Sonnentag P; Sharma AK; Timmers A; Robinson PM; Knop DR; Hauswirth WW; Chulay JD; Shearman MS; Ye GJ
    Hum Gene Ther Clin Dev; 2018 Dec; 29(4):188-197. PubMed ID: 30280954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Electrophysiologic Characteristics of a Large Kindred with X-Linked Retinitis Pigmentosa Associated with the RPGR Locus.
    Tzu JH; Arguello T; Berrocal AM; Berrocal M; Weisman AD; Liu M; Hess D; Caputo M; Goldberg JL; Feuer WJ; Stone EM; Lam BL
    Ophthalmic Genet; 2015; 36(4):321-6. PubMed ID: 24555744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
    Beltran WA; Cideciyan AV; Boye SE; Ye GJ; Iwabe S; Dufour VL; Marinho LF; Swider M; Kosyk MS; Sha J; Boye SL; Peterson JJ; Witherspoon CD; Alexander JJ; Ying GS; Shearman MS; Chulay JD; Hauswirth WW; Gamlin PD; Jacobson SG; Aguirre GD
    Mol Ther; 2017 Aug; 25(8):1866-1880. PubMed ID: 28566226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic high myopia in X-linked retinitis pigmentosa secondary to a novel mutation in the RPGR gene.
    Sanchez Tocino H; Diez Montero C; Villanueva Gómez A; Lobo Valentin R; Montero-Moreno JA
    Ophthalmic Genet; 2019 Apr; 40(2):170-176. PubMed ID: 31033374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic conservation in patients with X-linked retinitis pigmentosa caused by RPGR mutations.
    Zahid S; Khan N; Branham K; Othman M; Karoukis AJ; Sharma N; Moncrief A; Mahmood MN; Sieving PA; Swaroop A; Heckenlively JR; Jayasundera T
    JAMA Ophthalmol; 2013 Aug; 131(8):1016-25. PubMed ID: 23681342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel missense variant c.G644A (p.G215E) of the RPGR gene in a Chinese family causes X-linked retinitis pigmentosa.
    Fu J; Cheng J; Zhou Q; Wei C; Chen H; Lv H; Fu J
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Strategies for RPGR Gene Therapy.
    Cehajic Kapetanovic J; McClements ME; Martinez-Fernandez de la Camara C; MacLaren RE
    Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31487940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of microperimetry in RPGR-related retinitis pigmentosa: a review.
    Buckley TMW; Jolly JK; Josan AS; Wood LJ; Cehajic-Kapetanovic J; MacLaren RE
    Acta Ophthalmol; 2021 Dec; 99(8):819-825. PubMed ID: 33783139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.